Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VKTX
#1419
Viking Therapeutics, Inc. - Common Stock
37.9
6
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.42%
Monthly Change
+30.27%
6 month change
+9.97%
Year Change
+19.56%
Previous Close
38.1
2
Open
38.3
4
Low
37.9
3
High
38.3
9
Volume
1 021
Markets
US Stock Market
Healthcare
Biotechnology
VKTX
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
74.13 M
78.36 M
78.42 M
100.49 M
112.25 M
115.55 M
116.11 M
Valuation ratios
Enterprise value
388.25 M
334.1 M
631.49 M
1.78 B
4.49 B
3.9 B
4.52 B
Price to earnings ratio
10.35
6.46
-9.47
-20.09
-39.84
-11.03
-9.63
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
18.77
7.46
-13.53
-23.5
-49.98
-14.22
-13.32
Price to book ratio
1.67
1.76
4.5
4.95
4.98
6.2
1.7
Enterprise value to EBITDA ratio
—
—
—
-16.34
-26.7
-9.68
-8.87
Profitability ratios
Return on assets %
-0.15
-0.26
-0.41
-0.23
-0.12
-0.5
-0.26
Return on equity %
-0.16
-0.27
-0.47
-0.25
-0.12
-0.56
-0.32
Return on invested capital %
-11.89 K
-49.99 K
-28.77 K
-23.85 K
-37.93 K
-587.08 K
-436.21 K
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
21.12
23.98
7.61
19.19
33.09
9.33
5.72
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.3
-0.62
-0.63
-0.78
-0.81
-2.47
-3
EBIT per share
-0.59
-0.72
-0.92
-1.07
-1.38
-3.49
-4.42
EBITDA per share
—
—
—
-1.16
-1.54
-3.57
-4.49
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.42
2.62
2.02
3.84
8.28
6.26
5.22
Net current asset value per share
3.53
2.73
2.17
3.89
8.32
6.35
5.26
Tangible book value per share
3.37
2.62
1.89
3.69
8.07
5.67
4.34
Working capital per share
3.36
2.61
1.89
3.69
8.07
5.67
4.34
Book value per share
3.37
2.62
1.89
3.69
8.07
5.67
4.34
News
Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Viking Therapeutics: Still Cheap, But Watch Double Top (NASDAQ:VKTX)
NVO Rallies 11% in a Month: How Should Investors Play the Stock?
Buyout Buzz Around VKTX Is Back: What's Fueling the Speculation?
Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry (NYSE:NVO)
Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today
LLY Hits Another Record High: Is the Stock Too Expensive to Buy Now?
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
Can Medicare Bridge Help Novo Nordisk Defend Its GLP-1 Leadership?
Lilly Up Around 7% in a Week: Should You Buy, Sell or Hold the Stock?
Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Can Eli Lilly's New Drugs Fuel Growth Beyond Its GLP-1 Blockbusters?